Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 35 Carcinoma, Non-Small-Cell Lung 27 Breast Neoplasms 15 Lung Neoplasms 13 Neoplasm Metastasis 12 Triple Negative Breast Neoplasms 11 Neoplasms 10 Colorectal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Head and Neck Neoplasms 4 Carcinoma, Pancreatic Ductal 4 Stomach Neoplasms 3 Neoplasms by Site 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma 3 Adenocarcinoma 3 Vaccinia 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms by Histologic Type 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1

Interventions

Fluorouracil 14 pembrolizumab 13 Paclitaxel 13 Oxaliplatin 13 Leucovorin 10 Carboplatin 9 Radiotherapy 8 Capecitabine 8 Trastuzumab 7 Nivolumab 7 Drug Therapy 7 Cisplatin 7 Radiation 6 Esophagectomy 6 Taxes 5 Specimen Handling 5 Surgical Procedures, Operative 4 Irinotecan 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 Radiotherapy, Intensity-Modulated 3 Proton Therapy 3 Immunotherapy 3 Blood Specimen Collection 3 zanidatamab 2 ulixertinib 2 trastuzumab biosimilar HLX02 2 relatlimab 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × 130-nm albumin-bound paclitaxel × 90 days × Clear all

NCT07530094 2026-04-15

STELLAR01

Jiangsu Cancer Institute & Hospital

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡